Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it

Wendy Verónica Herrera-Morales, Leticia Ramírez-Lugo, Roger Cauich-Kumul, Eric Murillo-Rodríguez, Luis Núñez-Jaramillo

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations

Abstract

Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed pri-marily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although gener-ally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection based on individual patients’ physiological markers are being de-veloped. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.

Original languageEnglish
Pages (from-to)1236-1249
Number of pages14
JournalCurrent Topics in Medicinal Chemistry
Volume22
Issue number15
DOIs
StatePublished - 1 Jun 2022

Keywords

  • ADHD
  • Adverse reaction
  • Atomoxetine
  • Methylphenidate
  • Non-responder
  • Treatment personalization
  • qEEG-guided drug selection

Fingerprint

Dive into the research topics of 'Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it'. Together they form a unique fingerprint.

Cite this